DCVax-L

· Northwest Biotherapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DCVax-L, covering 2016-02-26 to 2022-05-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer [Phase 3]